| Grant number: | 25/05717-8 |
| Support Opportunities: | Scholarships in Brazil - Doctorate |
| Start date: | May 01, 2026 |
| End date: | October 31, 2028 |
| Field of knowledge: | Biological Sciences - Pharmacology - Neuropsychopharmacology |
| Principal Investigator: | Daniela Baptista de Souza |
| Grantee: | Silvia Jimena Cardenas Otero |
| Host Institution: | Faculdade de Ciências Farmacêuticas (FCFAR). Universidade Estadual Paulista (UNESP). Campus de Araraquara. Araraquara , SP, Brazil |
| Associated research grant: | 22/04387-6 - Sex differences and oxytocinergic transmission impact on chronic pain in animal models and humans, AP.JP |
Abstract Fibromyalgia (FM) involves a complex interaction between physical, emotional, and social challenges related to chronic pain. In Brazil, it is estimated that 2% of the population has FM, with a ratio of 1 man for every 5.5 women. Additionally, there is a high prevalence of affective-emotional disorders in patients suffering from chronic pain, with 37% diagnosed with depression and 16% with anxiety. The scientific literature highlights sex differences in the expression of genes, proteins, and neurotransmitters involved in pain. Despite this, preclinical studies have historically excluded females, creating a bias that affects the development of effective therapies for both sexes.The reserpine-induced FM model has proven to be an important tool for investigating the pathophysiology of the disease. The neuropeptide oxytocin has shown potential efficacy as an analgesic, with effects that vary according to biological sex. Thus, this study will integratively assess the impact of sexual dimorphism and oxytocinergic neurotransmission on the sensory, affective-emotional, and neurofunctional responses of fibromyalgia in male and female mice subjected to the experimental fibromyalgia model induced by reserpine. The following will be evaluated:(i) The influence of sex on sensory and affective-emotional components and plasma oxytocin levels;(ii) The effects of oxytocin treatment on behavioral and neurofunctional responses in the amygdaloid complex and spinal cord;(iii) The effects of oxytocinergic neurotransmission activation in the amygdaloid complex using genetically modified animals (Oxytocin-cre mice) on sensory and emotional responses.Through an approach that integrates behavioral, pharmacological, neurofunctional, and genetic aspects, the results of this study aim to clarify the influence of sexual dimorphism and the impact of oxytocinergic neurotransmission on the pathophysiology of FM, thereby contributing to the development of more effective therapies for the treatment of this pain condition. (AU) | |
| News published in Agência FAPESP Newsletter about the scholarship: | |
| More itemsLess items | |
| TITULO | |
| Articles published in other media outlets ( ): | |
| More itemsLess items | |
| VEICULO: TITULO (DATA) | |
| VEICULO: TITULO (DATA) | |